Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,125
Closed -$307K 248
2025
Q4
$307K Buy
4,125
+437
+12% +$31.9K 0.05% 160
2025
Q3
$252K Sell
3,688
-1,646
-31% -$109K 0.05% 181
2025
Q2
$350K Sell
5,334
-10,824
-67% -$649K 0.07% 128
2025
Q1
$940K Buy
16,158
+13,119
+432% +$869K 0.24% 64
2024
Q4
$219K Sell
3,039
-430
-12% -$33.6K 0.06% 159
2024
Q3
$283K Buy
3,469
+39
+1% +$3.12K 0.08% 132
2024
Q2
$283K Buy
3,430
+289
+9% +$21.7K 0.09% 117
2024
Q1
$235K Buy
+3,141
New +$234K 0.08% 128

Other funds holding HOLX

Canvas Wealth Advisors's HOLX Position: Q1 2026 in Review

Canvas Wealth Advisors sold out of Hologic (HOLX) in Q1 2026, closing a stake of 4,125 shares — an estimated $307K sold.

Canvas Wealth Advisors first reported a position in HOLX in Q1 2024 and held it in 8 quarters. The position peaked at $940K in Q1 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Canvas Wealth Advisors reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Canvas Wealth Advisors sold 4,125 Hologic shares in Q1 2026, an estimated $307K.
  • Canvas Wealth Advisors first reported a position in Hologic in Q1 2024 and held it in 8 quarters.
  • Canvas Wealth Advisors's Hologic position peaked at $940K in Q1 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Canvas Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.